<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Dermatol</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Dermatol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1365-2133</journal-id><journal-id journal-id-type="publisher-id">BJD</journal-id><journal-title-group><journal-title>The British Journal of Dermatology</journal-title></journal-title-group><issn pub-type="ppub">0007-0963</issn><issn pub-type="epub">1365-2133</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6850467</article-id><article-id pub-id-type="doi">10.1111/bjd.17698</article-id><article-id pub-id-type="publisher-id">BJD17698</article-id><article-categories><subj-group subj-group-type="overline"><subject>Translational Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject><subj-group subj-group-type="heading"><subject>Translational Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer&#x02010;prone genodermatoses</article-title><alt-title alt-title-type="left-running-head">E. Chac&#x000f3;n&#x02010;Solano <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="bjd17698-cr-0001" contrib-type="author"><name><surname>Chac&#x000f3;n&#x02010;Solano</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bjd17698-cr-0002" contrib-type="author"><name><surname>Le&#x000f3;n</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bjd17698-cr-0003" contrib-type="author"><name><surname>D&#x000ed;az</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bjd17698-cr-0004" contrib-type="author"><name><surname>Garc&#x000ed;a&#x02010;Garc&#x000ed;a</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="bjd17698-cr-0005" contrib-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="bjd17698-cr-0006" contrib-type="author"><name><surname>Esc&#x000e1;mez</surname><given-names>M.J.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="bjd17698-cr-0007" contrib-type="author"><name><surname>Guerrero&#x02010;Aspizua</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="bjd17698-cr-0008" contrib-type="author"><name><surname>Conti</surname><given-names>C.J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4753-0722</contrib-id><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bjd17698-cr-0009" contrib-type="author"><name><surname>Menc&#x000ed;a</surname><given-names>&#x000c1;.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bjd17698-cr-0010" contrib-type="author"><name><surname>Mart&#x000ed;nez&#x02010;Santamar&#x000ed;a</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bjd17698-cr-0011" contrib-type="author"><name><surname>Llames</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0004">
<sup>4</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="bjd17698-cr-0012" contrib-type="author"><name><surname>P&#x000e9;vida</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="bjd17698-cr-0013" contrib-type="author"><name><surname>Carbonell&#x02010;Caballero</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="bjd17698-cr-0014" contrib-type="author"><name><surname>Puig&#x02010;Butill&#x000e9;</surname><given-names>J.A.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="bjd17698-cr-0015" contrib-type="author"><name><surname>Maseda</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="bjd17698-cr-0016" contrib-type="author"><name><surname>Puig</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="bjd17698-cr-0017" contrib-type="author"><name><surname>de Lucas</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="bjd17698-cr-0018" contrib-type="author"><name><surname>Baselga</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0009">
<sup>9</sup>
</xref></contrib><contrib id="bjd17698-cr-0019" contrib-type="author" corresp="yes"><name><surname>Larcher</surname><given-names>F.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6771-3561</contrib-id><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0004">
<sup>4</sup>
</xref><address><email>fernando.larcher@ciemat.es</email></address></contrib><contrib id="bjd17698-cr-0020" contrib-type="author" corresp="yes"><name><surname>Dopazo</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0010">
<sup>10</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0011">
<sup>11</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0012">
<sup>12</sup>
</xref><address><email>joaquin.dopazo@juntadeandalucia.es</email></address></contrib><contrib id="bjd17698-cr-0021" contrib-type="author" corresp="yes"><name><surname>del R&#x000ed;o</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="bjd17698-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="bjd17698-aff-0004">
<sup>4</sup>
</xref><address><email>mrnechae@ing.uc3m.es</email></address></contrib></contrib-group><aff id="bjd17698-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Bioengineering</named-content>
<institution>Universidad Carlos III de Madrid</institution>
<city>Madrid</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0002">
<label><sup>2</sup></label>
<institution>Regenerative Medicine and Tissue Engineering Group</institution>
<institution>Fundaci&#x000f3;n Jim&#x000e9;nez D&#x000ed;az (IIS&#x02010;FJD)</institution>
<city>Madrid</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0003">
<label><sup>3</sup></label>
<institution>Bioinformatics and Biostatistics Unit</institution>
<institution>Centro de Investigaci&#x000f3;n Pr&#x000ed;ncipe Felipe (CIPF)</institution>
<city>Valencia</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Epithelial Biomedicine Division</named-content>
<institution>CIEMAT&#x02010;CIBERER (U714)</institution>
<city>Madrid</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Tissue Engineering Unit</named-content>
<institution>Centro Comunitario Sangre y Tejidos (CCST)</institution>
<city>Oviedo</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0006">
<label><sup>6</sup></label>
<institution>Department of Computational Genomics</institution>
<institution>Centro de Investigaci&#x000f3;n Pr&#x000ed;ncipe Felipe (CIPF)</institution>
<city>Valencia</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0007">
<label><sup>7</sup></label>
<institution>Melanoma Unit</institution>
<institution>Hospital Clinic &#x00026; IDIBAPS (Institut d'Investigacions Biom&#x000e8;diques Agust&#x000ed; Pi i Sunyer), CIBERER (U726), Universitat de Barcelona</institution>
<city>Barcelona</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Department of Pediatric Dermatology</named-content>
<institution>La Paz Hospital</institution>
<city>Madrid</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Department of Pediatric Dermatology</named-content>
<institution>Santa Creu I Sant Pau Hospital</institution>
<city>Barcelona</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Clinical Bioinformatics Area</named-content>
<institution>Fundaci&#x000f3;n Progreso y Salud</institution>
<institution>CDCA, Hospital Virgen del Roc&#x000ed;o</institution>
<city>Sevilla</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0011">
<label><sup>11</sup></label>
<named-content content-type="organisation-division">Functional Genomics Node</named-content>
<institution>INB&#x02010;ELIXIR&#x02010;es, FPS, Hospital Virgen del Roc&#x000ed;o</institution>
<city>Sevilla</city>
<country country="ES">Spain</country>
</aff><aff id="bjd17698-aff-0012">
<label><sup>12</sup></label>
<named-content content-type="organisation-division">Bioinformatics in Rare Diseases (BiER&#x02010;U715)</named-content>
<institution>CIBERER</institution>
<institution>FPS, Hospital Virgen del Roc&#x000ed;o</institution>
<city>Sevilla</city>
<country country="ES">Spain</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence<break/>
Fernando Larcher; Joaquin Dopazo; Marcela Del R&#x000ed;o.<break/>
E&#x02010;mails: <email>fernando.larcher@ciemat.es</email>; <email>joaquin.dopazo@juntadeandalucia.es</email>; <email>mrnechae@ing.uc3m.es</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2019</year></pub-date><volume>181</volume><issue>3</issue><issue-id pub-id-type="doi">10.1111/bjd.v181.3</issue-id><fpage>512</fpage><lpage>522</lpage><history><date date-type="accepted"><day>24</day><month>1</month><year>2019</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 British Association of Dermatologists <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2019 The Authors. <italic>British Journal of Dermatology</italic> published by John Wiley &#x00026; Sons Ltd on behalf of British Association of Dermatologists</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:BJD-181-512.pdf"/><abstract id="bjd17698-abs-0001"><title>Summary</title><sec id="bjd17698-sec-0001"><title>Background</title><p>Recessive dystrophic epidermolysis bullosa (<styled-content style="fixed-case" toggle="no">RDEB</styled-content>), Kindler syndrome (<styled-content style="fixed-case" toggle="no">KS</styled-content>) and xeroderma pigmentosum complementation group C (<styled-content style="fixed-case" toggle="no">XPC</styled-content>) are three cancer&#x02010;prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders.</p></sec><sec id="bjd17698-sec-0002"><title>Objectives</title><p>To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of <styled-content style="fixed-case" toggle="no">RDEB</styled-content>,<styled-content style="fixed-case" toggle="no"> KS</styled-content> and <styled-content style="fixed-case" toggle="no">XPC</styled-content>.</p></sec><sec id="bjd17698-sec-0003"><title>Methods</title><p>We conducted <styled-content style="fixed-case" toggle="no">RNA</styled-content>&#x02010;Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies.</p></sec><sec id="bjd17698-sec-0004"><title>Results</title><p>Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix (<styled-content style="fixed-case" toggle="no">ECM</styled-content>) proteins. Western blot and immunofluorescence <italic>in&#x000a0;situ</italic> analyses validated the <styled-content style="fixed-case" toggle="no">RNA</styled-content>&#x02010;Seq data. In addition, enzyme&#x02010;linked immunosorbent assay revealed increased circulating levels of periostin in patients with <styled-content style="fixed-case" toggle="no">RDEB</styled-content>.</p></sec><sec id="bjd17698-sec-0005"><title>Conclusions</title><p>Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury&#x02010;sensitive events. These, in turn, trigger a cascade of reactions involving abnormal <styled-content style="fixed-case" toggle="no">ECM</styled-content> deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in <styled-content style="fixed-case" toggle="no">RDEB</styled-content>,<styled-content style="fixed-case" toggle="no"> XPC</styled-content> and <styled-content style="fixed-case" toggle="no">KS</styled-content>.</p></sec><sec id="bjd17698-sec-2005"><p>
<bold>What's already known about this topic?</bold>
</p><p>
<list list-type="bullet" id="bjd17698-list-0001"><list-item><p>Recessive dystrophic epidermolysis bullosa (<styled-content style="fixed-case" toggle="no">RDEB</styled-content>), Kindler syndrome (<styled-content style="fixed-case" toggle="no">KS</styled-content>) and xeroderma pigmentosum complementation group C (<styled-content style="fixed-case" toggle="no">XPC</styled-content>) are three genodermatoses with high predisposition to cancer development.</p></list-item><list-item><p>Although their causal genetic mutations mainly affect epithelia, the dermal microenvironment likely contributes to the physiopathology of these disorders.</p></list-item></list>
</p><p>
<bold>What does this study add?</bold>
</p><p>
<list list-type="bullet" id="bjd17698-list-0002"><list-item><p>We disclose a large overlapping transcription profile between XPC, KS and RDEB fibroblasts that points towards an activated phenotype with high matrix&#x02010;synthetic capacity.</p></list-item><list-item><p>This common signature seems to be independent of the primary causal deficiency, but reflects an underlying derangement of the extracellular matrix via transforming growth factor&#x02010;&#x003b2; signalling activation and oxidative state imbalance.</p></list-item></list>
</p><p>
<bold>What is the translational message?</bold>
</p><p>
<list list-type="bullet" id="bjd17698-list-0003"><list-item><p>This study broadens the current knowledge about the pathology of these diseases and highlights new targets and biomarkers for effective therapeutic intervention.</p></list-item><list-item><p>It is suggested that high levels of circulating periostin could represent a potential biomarker in RDEB.</p></list-item></list>
</p></sec></abstract><abstract abstract-type="short" id="bjd17698-abs-1101"><p>
<bold>Linked Comment</bold>: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bjd.18104">https://doi.org/10.1111/bjd.18104</ext-link>.</p><p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bjd.18271">https://doi.org/10.1111/bjd.18271</ext-link> available online</p></abstract><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Comunidad de Madrid </institution><institution-id institution-id-type="open-funder-registry">10.13039/100012818</institution-id></institution-wrap></funding-source><award-id>AvanCell&#x02010;CM S2017/BMD&#x02010;3692</award-id></award-group><award-group id="funding-0002"><funding-source>Catalan Government</funding-source><award-id>AGAUR 2014_SGR_603</award-id></award-group><award-group id="funding-0003"><funding-source>Ministerio de Econom&#x000ed;a y Competitividad</funding-source><award-id>SAF2013&#x02010;43475R</award-id><award-id>SAF2017&#x02010;86810&#x02010;R</award-id><award-id>SAF2017&#x02010;88908&#x02010;R</award-id></award-group><award-group id="funding-0004"><funding-source>European Union</funding-source><award-id>H2020&#x02010;INFRADEV&#x02010;1&#x02010;2015&#x02010;1 / ELIXIR&#x02010;EXCELERATE&#x02010;ref.67</award-id><award-id>HEALTH&#x02010;F2&#x02010;2011&#x02010;261392</award-id></award-group><award-group id="funding-0005"><funding-source><institution-wrap><institution>Instituto de Salud Carlos III </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100004587</institution-id></institution-wrap></funding-source><award-id>PI14/00931</award-id><award-id>PI15/00716</award-id><award-id>PI15/00956</award-id><award-id>PI17/01747</award-id><award-id>PT13/0001/0007</award-id><award-id>PT17/0009/0006</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="1"/><page-count count="11"/><word-count count="6621"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2019</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.1 mode:remove_FC converted:12.11.2019</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="bjd17698-ntgp-0001"><fn fn-type="funding" id="bjd17698-note-1001"><p>
<bold>Funding sources</bold> This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2013&#x02010;43475R, SAF2017&#x02010;88908&#x02010;R and SAF2017&#x02010;86810&#x02010;R); from Instituto de Salud Carlos III and CIBERER, cofunded with European Regional Development Funds (ERDF) (PT13/0001/0007, PI14/00931, PI15/00716, PI15/00956, PT17/0009/0006 and PI17/01747); and from the European Union (HEALTH&#x02010;F2&#x02010;2011&#x02010;261392 and H2020&#x02010;INFRADEV&#x02010;1&#x02010;2015&#x02010;1/ELIXIR&#x02010;EXCELERATE&#x02010;ref.676559). Additional funding from Comunidad de Madrid (AvanCell&#x02010;CM S2017/BMD&#x02010;3692); Catalan Government (AGAUR 2014_SGR_603); &#x02018;Fundaci&#x000f3; La Marat&#x000f3; de TV3, 201331&#x02010;30&#x02019;; CERCA Programme/Generalitat de Catalunya; and &#x02018;Fundaci&#x000f3;n Cient&#x000ed;fica de la Asociaci&#x000f3;n Espa&#x000f1;ola Contra el C&#x000e1;ncer&#x02019;, Spain.</p></fn><fn id="bjd17698-note-1002"><p>
<bold>Conflicts of interest</bold> None to declare.</p></fn><fn fn-type="equal" id="bjd17698-note-1003"><p>
<italic>E.C.S., C.L. and F.D. contributed equally</italic>
</p></fn><fn id="bjd17698-note-1202"><p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bjd.18271">https://doi.org/10.1111/bjd.18271</ext-link> available online</p></fn></fn-group></notes></front><body id="bjd17698-body-0001"><p>The progress made in molecular genetics has greatly contributed to identifying the primary causes of a large number of heritable skin diseases.<xref rid="bjd17698-bib-0001" ref-type="ref">1</xref> However, these findings do not always explain by themselves the complex phenotypic manifestations observed in cancer&#x02010;prone genodermatoses, such as recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC). RDEB is caused by loss&#x02010;of&#x02010;function mutations in the <italic>COL7A1</italic> gene, which encodes type VII collagen (C7) anchoring fibrils, structures that connect the epidermal basement membrane to the dermal tissue. C7 deficiency causes loss of dermoepidermal adhesion, resulting in blister formation, scarring and aggressive carcinoma development.<xref rid="bjd17698-bib-0002" ref-type="ref">2</xref>
</p><p>KS results from recessive mutations in the <italic>FERMT1</italic> gene, encoding kindlin&#x02010;1. This protein mediates anchorage between the actin cytoskeleton and the extracellular matrix (ECM) via focal adhesions. KS is characterized clinically by early&#x02010;age acral skin blisters, photosensitivity and high risk of mucocutaneous malignancies.<xref rid="bjd17698-bib-0003" ref-type="ref">3</xref>, <xref rid="bjd17698-bib-0004" ref-type="ref">4</xref>, <xref rid="bjd17698-bib-0005" ref-type="ref">5</xref> XPC is characterized by mutations in the <italic>XPC</italic> gene, which cause a severe deficiency in the nucleotide excision repair pathway. Patients with XPC are highly sensitive to ultraviolet radiation and have a very high risk of developing skin tumours in sun&#x02010;exposed areas, mostly basal and squamous cell carcinomas arising from epidermal keratinocytes, and malignant melanomas.<xref rid="bjd17698-bib-0006" ref-type="ref">6</xref> Patients with XPC also have a high risk of developing tumours in internal organs not exposed to sunlight.<xref rid="bjd17698-bib-0007" ref-type="ref">7</xref>
</p><p>Besides cancer susceptibility, other common clinical signs to the three genodermatoses are inflammation and premature skin ageing.<xref rid="bjd17698-bib-0008" ref-type="ref">8</xref>, <xref rid="bjd17698-bib-0009" ref-type="ref">9</xref>, <xref rid="bjd17698-bib-0010" ref-type="ref">10</xref> Although the specific primary and subsequent genetic alterations at the epidermal level are likely to be major drivers for carcinogenesis in these disorders, an altered stroma may play a facilitating role towards tumour development and malignant progression.</p><p>Robust data, gathered mainly from omics studies of patient cells and mouse models, underscore the role of aberrant ECM deposition, leading to progressive fibrosis and cutaneous squamous cell carcinoma (cSCC) in RDEB. This process appears to be mediated by the dermal fibroblasts, which acquire molecular changes similar to those present in the tumour microenvironment (i.e. cancer&#x02010;associated fibroblasts; CAFs).<xref rid="bjd17698-bib-0011" ref-type="ref">11</xref> Less is known in this regard for KS and XPC, although marginal evidence indicates that fibroblasts may also be relevant in the disease pathogenesis.<xref rid="bjd17698-bib-0012" ref-type="ref">12</xref>, <xref rid="bjd17698-bib-0013" ref-type="ref">13</xref>, <xref rid="bjd17698-bib-0014" ref-type="ref">14</xref>, <xref rid="bjd17698-bib-0015" ref-type="ref">15</xref> Here we demonstrate through RNA&#x02010;Seq analysis and expression validation of relevant genes that RDEB, XPC and KS fibroblasts allow establishment of a common profibrotic microenvironment that could favour disease progression and cancer.</p><sec id="bjd17698-sec-0007"><title>Materials and methods</title><sec id="bjd17698-sec-0008"><title>Sample collection and cell culture</title><p>All procedures were approved by the ethics committee of La Paz University Hospital (code HULP: PI&#x02010;1602) and were conducted in accordance with the Declaration of Helsinki and subsequent revisions. Skin biopsies from unaffected areas of seven healthy donors, 11 patients with RDEB, four patients with KS and four patients with XPC were obtained after written informed consent was obtained. Fibroblasts were isolated by mechanical and enzymatic digestion as previously described.<xref rid="bjd17698-bib-0016" ref-type="ref">16</xref> They were cultured in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum (both Thermo Fisher Scientific, Waltham, MA, U.S.A. and Invitrogen, Carlsbad, CA, U.S.A.) and 1% Antibiotic&#x02010;Antimycotic (Thermo Fisher Scientific). The characteristics of the patients and controls can be seen in Table&#x000a0;<xref rid="bjd17698-sup-0003" ref-type="supplementary-material">S1</xref> (see Supporting Information). All cells used were at early three to seven passages (see Table S1).</p></sec><sec id="bjd17698-sec-0009"><title>RNA extraction</title><p>Culture medium was changed 24 h before harvesting the cells. Total RNA was isolated from confluent primary fibroblasts using an RNeasy Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol recommendations. RNA concentration and quality were determined on a NanoDrop Spectrophotometer (Thermo Scientific Inc.) and integrity was verified with a Bioanalyzer 2100 (Agilent, Santa Clara, CA, U.S.A.). The RNA integrity number in all cases was higher than 8&#x000b7;5. To minimize technical variability, RNA extracts from four technical replicates of each sample were mixed.</p></sec><sec id="bjd17698-sec-0010"><title>RNA&#x02010;Seq data processing</title><p>cDNA libraries were generated for each sample using the TruSeq RNA Sample Preparation Kit (Illumina, San Diego, CA, U.S.A.) according to the recommended protocol. Ligation and library integrity were verified using an Agilent Bioanalyzer 2100. Sample libraries ligated with unique adapter sequences were multiplexed six to a lane and were sequenced by Edinburgh Genomics (Edinburgh, U.K.) using Illumina HiSeq HO v4 125 paired end sequencing. Quality control analysis on the resulting FASTQ files was performed using FastQC (Babraham Bioinformatics, Cambridge, U.K.). Reads were adapter trimmed using cutadapt version 1&#x000b7;3 (<ext-link ext-link-type="uri" xlink:href="https://pypi.org/project/cutadapt/13">https://pypi.org/project/cutadapt/13</ext-link>) with the parameters &#x02010;q 30 &#x02010;m 50 &#x02010;a AGATCGGAAGAGC. Trimmed reads were aligned to Ensembl version 38&#x000b7;81 of the <italic>Homo sapiens</italic> genome with TopHat2 version 2&#x000b7;0&#x000b7;13 (<ext-link ext-link-type="uri" xlink:href="https://ccb.jhu.edu/software/tophat">https://ccb.jhu.edu/software/tophat</ext-link>) using default parameters, except &#x02018;&#x02010;r &#x02010;70 &#x02010;mate&#x02010;std&#x02010;dev 75&#x02019; to specify insert sizes. The BAM files were sorted by name using Picard&#x02010;tools version 1&#x000b7;115 SortSam (<ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard">https://broadinstitute.github.io/picard</ext-link>). Read counts were generated using HTSeq&#x02010;count version 0&#x000b7;6&#x000b7;0 in unstranded mode (<ext-link ext-link-type="uri" xlink:href="https://htseq.readthedocs.io">https://htseq.readthedocs.io</ext-link>) and Python version 2&#x000b7;7&#x000b7;3, with parameters &#x02010;m union &#x02010;i gene_id &#x02010;t exon. Raw and processed data are stored at the National Center for Biotechnology Information's Gene Expression Omnibus, accession code <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE119501">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE119501</ext-link>.</p><p>RNA&#x02010;Seq data were normalized using the Trimmed Mean of <italic>M</italic>&#x02010;values.<xref rid="bjd17698-bib-0017" ref-type="ref">17</xref> An adjustment for possible batch effects was performed using the R package ComBat.<xref rid="bjd17698-bib-0018" ref-type="ref">18</xref> The transcripts that had an average expression per condition &#x0003c; 1 count per million and a coefficient of variation per condition &#x0003e; 100% were filtered. Differential expression analysis was performed with the Bioconductor package edgeR.<xref rid="bjd17698-bib-0019" ref-type="ref">19</xref> The conventional multiple&#x02010;testing <italic>P</italic>&#x02010;value correction procedure proposed by Benjamini and Hochberg was used to derive adjusted <italic>P</italic>&#x02010;values.<xref rid="bjd17698-bib-0020" ref-type="ref">20</xref> Enrichment analysis was carried out for the gene ontology terms using the Babelomics suite<xref rid="bjd17698-bib-0021" ref-type="ref">21</xref> and DAVID bioinformatic resources.<xref rid="bjd17698-bib-0022" ref-type="ref">22</xref>
</p></sec><sec id="bjd17698-sec-0011"><title>Pathway activity analysis and protein&#x02013;protein interaction</title><p>The signalling circuit activity analysis method,<xref rid="bjd17698-bib-0023" ref-type="ref">23</xref> as implemented in the hiPathia R package (<ext-link ext-link-type="uri" xlink:href="https://github.com/babelomics/hipathia">https://github.com/babelomics/hipathia</ext-link>), was applied to all disease vs. healthy control comparisons. Under this modelling schema, signalling circuits are defined within Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways as the chain of proteins that connect a receptor protein to an effector protein that triggers specific cellular activities. The signal is propagated from the receptor protein along the proteins that compose the circuit by a recursive formula that takes into account the activity of both activator and inhibitor proteins. Finally, the list of the common dysregulated genes in all disease vs. control comparisons was uploaded to STRING,<xref rid="bjd17698-bib-0024" ref-type="ref">24</xref> a database that represents the known protein&#x02013;protein interactions (PPIs). The minimum required interaction score was set to &#x0003e; 0&#x000b7;7, allowing only high&#x02010;confidence connections between nodes.</p></sec><sec id="bjd17698-sec-0012"><title>Western blot analysis</title><p>Primary fibroblasts, serum starved for 24 h, were lysed with 25&#x02010;mmol L<sup>&#x02212;1</sup> Tris&#x02010;HCl (pH 7&#x000b7;4), 100&#x02010;mmol L<sup>&#x02212;1</sup> NaCl, 1% Nonidet P&#x02010;40 and protease inhibitor cocktail (Roche Diagnostics Limited, Burgess Hill, U.K.). The extracts were cleared of cellular debris by centrifugation at 16&#x000a0;000 <italic><bold>g</bold></italic> for 15 min at 4 &#x000b0;C. Protein extracts were electrophoresed on sodium dodecylsulfate polyacrylamide 4&#x02013;12% Bis&#x02010;Tris gel and transferred onto nitrocellulose membranes. The membranes were blocked with 5% nonfat milk powder in 1X Tris&#x02010;buffered saline for 1&#x000a0;h at room temperature and incubated overnight with one of the following antibodies: antitenascin C (MAB2138; R&#x00026;D Systems Inc., Minneapolis, MN, U.S.A.), anti&#x02010;&#x003b2;IG&#x02010;H3 (D31B8; Cell Signaling Technology, Beverly, MA, U.S.A.), anti&#x02010;ALDH1A1 (EP1933Y; Abcam, Cambridge, U.K.), antiperiostin (sc&#x02010;398631) antifibulin&#x02010;1 (sc&#x02010;25281), anti&#x02010;TGase2 (sc&#x02010;48387) and anti&#x02010;GAPDH (sc&#x02010;25778; all Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). Detection was performed using horseradish peroxidase&#x02010;conjugated secondary antibodies and a chemiluminescent detection assay (SuperSignal West, Thermo Fisher Scientific). Three independent experiments were performed for each patient sample and control.</p></sec><sec id="bjd17698-sec-0013"><title>Immunofluorescence analysis</title><p>Skin cryosections from three healthy donors, two patients with RDEB and two patients with KS were immunostained against tenascin C (MAB2138) and periostin (sc&#x02010;398631). Fluorescence quantification was measured using the ImageJ program (<ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij">https://imagej.nih.gov/ij</ext-link>). Student's <italic>t</italic>&#x02010;test was applied to compare the fluorescence intensity/area means of samples, using GraphPad Prism 5&#x000b7;04 (GraphPad Software, La Jolla, CA, U.S.A.).</p></sec><sec id="bjd17698-sec-0014"><title>Enzyme&#x02010;linked immunosorbent assay</title><p>Serum samples from 16 patients with RDEB and 10 healthy donors (Table&#x000a0;<xref rid="bjd17698-sup-0003" ref-type="supplementary-material">S1b</xref>; see Supporting Information) were analysed using a human periostin enzyme&#x02010;linked immunosorbent assay kit (EHPOSTN&#x02010;PL; Thermo Fisher Scientific) according to the manufacturer's protocol. The absorbance was measured at 450 nm and 550 nm with a microtitre plate reader (Tecan Genios Pro; Tecan Austria GmbH, Gr&#x000f6;dig, Austria). The D'Agostino&#x02013;Pearson omnibus test was applied to determine whether the values had a normal distribution. An unpaired <italic>t</italic>&#x02010;test with Welch's correction was done to determine the statistical significance between patients with RDEB and controls (in GraphPad Prism 5&#x000b7;04). Two independent experiments were performed for each patient sample and for controls.</p></sec></sec><sec id="bjd17698-sec-0015"><title>Results</title><sec id="bjd17698-sec-0016"><title>Patients with genodermatoses and mutations</title><p>Patients were screened for <italic>COL7A1</italic>,<italic> XPC</italic> and <italic>FERMT1</italic> specific mutations, according to the diagnosed disease (Table&#x000a0;<xref rid="bjd17698-sup-0003" ref-type="supplementary-material">S1a</xref>; see Supporting Information). All patients with RDEB were homozygous for a <italic>COL7A1</italic> recurrent mutation (c.6527insC), leading to a premature termination codon.<xref rid="bjd17698-bib-0025" ref-type="ref">25</xref> All of the screened patients with XPC carried a homozygous frameshift mutation (c.1643_1644delTG) in <italic>XPC</italic>, resulting in a premature termination codon. Finally, patients with KS were the most heterogeneous group, with three different homozygous mutations in <italic>FERMT1</italic>. Sample KS1 produced altered splicing due to insertion of a new triplet (c.1371+4&#x0003e;G), KS2 has a missense variant (c.1198T&#x0003e;C) and KS3 has a frameshift mutation (c.676dupC).</p></sec><sec id="bjd17698-sec-0017"><title>Identification of common expression signatures linked to fibroblast activation and extracellular matrix deposition</title><p>RNA&#x02010;Seq counts were obtained for primary fibroblasts isolated from three healthy donors, nine patients with RDEB, three patients with KS and three patients with XPC. In total 22&#x000a0;970 transcripts, identified by their Ensembl IDs, were obtained for each sample after data quality assessment and normalization (Table&#x000a0;<xref rid="bjd17698-sup-0004" ref-type="supplementary-material">S2</xref>; see Supporting Information). The observed arrangement of the samples in the principal component analysis discarded any possible batch effect and organized the samples following the different disease groups. Notably, all genodermatosis samples are located in proximity within the plot, and are distinctly separated from controls (Fig.&#x000a0;<xref rid="bjd17698-fig-0001" ref-type="fig">1</xref>a), pointing towards a similar transcription profile between the three genodermatoses.</p><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Differential gene expression profile. (a) Principal component analysis plot representing the global distribution of each sequenced sample, after data processing and normalization. Disease samples tended to group together and distantly from the controls. (b) An overlapping set of 227 transcripts commonly dysregulated in all of the diseases. (c) Heat map of the normalized expression of the 227 transcripts (red, upregulated; green, downregulated in the disease). (d) Linear regression of fold changes of the 227 transcripts (blue dots) shows an impressive positive correlation (<italic>R</italic>
<sup>2</sup> = 0&#x000b7;895). Axes indicate the fold&#x02010;change values (logarithmic scale). <styled-content style="fixed-case" toggle="no">RDEB</styled-content>, recessive dystrophic epidermolysis bullosa; <styled-content style="fixed-case" toggle="no">KS</styled-content>, Kindler syndrome; <styled-content style="fixed-case" toggle="no">XPC</styled-content>, xeroderma pigmentosum complementation group C; Ctrl, healthy control.</p></caption><graphic id="nlm-graphic-1" xlink:href="BJD-181-512-g001"/></fig><p>In order to identify the dysregulated genes, differential expression analysis was carried out, contrasting each disease group (RDEB, KS or XPC) vs. healthy controls (Table&#x000a0;<xref rid="bjd17698-sup-0005" ref-type="supplementary-material">S3</xref>). The number of differentially expressed genes (false discovery rate &#x0003c; 0&#x000b7;05) in the different comparisons is detailed in Table&#x000a0;<xref rid="bjd17698-tbl-0001" ref-type="table">1</xref>. A Venn diagram of the different comparisons revealed an intersection of 227 common dysregulated transcripts (containing 186 genes) in the three genodermatoses (Fig.&#x000a0;<xref rid="bjd17698-fig-0001" ref-type="fig">1</xref>b). Interestingly, all of these transcripts (129 upregulated and 98 downregulated) showed not only the same expression pattern (Fig.&#x000a0;<xref rid="bjd17698-fig-0001" ref-type="fig">1</xref>c), but also an impressive positive correlation between the fold changes (Fig.&#x000a0;<xref rid="bjd17698-fig-0001" ref-type="fig">1</xref>d). This suggests that the common expression profile may have a similar phenotypic impact on the three diseases.</p><table-wrap id="bjd17698-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Number of genes differentially expressed in each genodermatosis vs. healthy controls</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Comparison</th><th align="left" valign="top" rowspan="1" colspan="1">Underexpressed</th><th align="left" valign="top" rowspan="1" colspan="1">Overexpressed</th><th align="char" char=" " valign="top" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RDEB vs. control</td><td align="left" rowspan="1" colspan="1">516</td><td align="left" rowspan="1" colspan="1">327</td><td align="char" char=" " rowspan="1" colspan="1">843</td></tr><tr><td align="left" rowspan="1" colspan="1">KS vs. control</td><td align="left" rowspan="1" colspan="1">196</td><td align="left" rowspan="1" colspan="1">180</td><td align="char" char=" " rowspan="1" colspan="1">376</td></tr><tr><td align="left" rowspan="1" colspan="1">XPC vs. control</td><td align="left" rowspan="1" colspan="1">523</td><td align="left" rowspan="1" colspan="1">509</td><td align="char" char=" " rowspan="1" colspan="1">1032</td></tr></tbody></table><table-wrap-foot id="bjd17698-ntgp-0002"><fn id="bjd17698-note-0004"><p>RDEB, recessive dystrophic epidermolysis bullosa; KS, Kindler syndrome; XPC, xeroderma pigmentosum complementation group C.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Common expression patterns are best understood through the examination of enriched gene ontology terms<xref rid="bjd17698-bib-0026" ref-type="ref">26</xref> and KEGG pathways.<xref rid="bjd17698-bib-0027" ref-type="ref">27</xref> This approach provides an undirected method to highlight those biological mechanisms that could be potentially relevant to the diseases. The output of this enrichment analysis is a list of pathways and/or ontologies that involve a statistically significant number of dysregulated genes, associated with the same biological mechanism (Fig.&#x000a0;<xref rid="bjd17698-fig-0002" ref-type="fig">2</xref>, Table&#x000a0;<xref rid="bjd17698-sup-0006" ref-type="supplementary-material">S4</xref>; see Supporting Information).</p><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Enrichment analysis of differentially expressed genes. Within the specific alterations of each disease, enriched gene ontology (<styled-content style="fixed-case" toggle="no">GO</styled-content>) terms highlight common abnormalities in the three genodermatoses with respect to cell periphery, extracellular matrix (<styled-content style="fixed-case" toggle="no">ECM</styled-content>) and activity of transcription factors. Kyoto Encyclopedia of Genes and Genomes (<styled-content style="fixed-case" toggle="no">KEGG</styled-content>) pathways reveal enriched categories related with cancer, phosphoinositol&#x02010;3&#x02010;kinase (<styled-content style="fixed-case" toggle="no">PI</styled-content>3K)&#x02013;Akt and chemokine signalling. The highest&#x02010;ranked categories in each disease are shown according to the <italic>P</italic>&#x02010;value and percentage of genes. <styled-content style="fixed-case" toggle="no">RDEB</styled-content>, recessive dystrophic epidermolysis bullosa; <styled-content style="fixed-case" toggle="no">KS</styled-content>, Kindler syndrome; <styled-content style="fixed-case" toggle="no">XPC</styled-content>, xeroderma pigmentosum complementation group C; Ctrl, healthy control; <styled-content style="fixed-case" toggle="no">TNF</styled-content>, tumour necrosis factor.</p></caption><graphic id="nlm-graphic-3" xlink:href="BJD-181-512-g002"/></fig><p>Enriched gene ontology terms for all of the diseases point towards an abnormal relationship between the cell and its stroma. This suggests that the contribution of dermal fibroblasts to the disease lies in the altered response they exert on the surrounding microenvironment. The dysregulated genes were significantly associated with ECM and the cell periphery (cellular component). Furthermore, glycosaminoglycan binding, sulfur compound binding and heparin binding &#x02013; which point towards ECM components &#x02013; are over&#x02010;represented (molecular function). Apart from these terms, altered activity of transcription factors is also noticeable, presumably associated with the observed differences in gene transcription. KEGG pathway analysis identified common alterations in phosphoinositol&#x02010;3&#x02010;kinase (PI3K)&#x02013;Akt signalling, the chemokine repertoire and two cancer&#x02010;related pathways (highlighted terms in Table&#x000a0;<xref rid="bjd17698-sup-0006" ref-type="supplementary-material">S4</xref>; see Supporting Information).</p><p>To gain a deeper insight into the altered mechanisms, we employed the web tool hiPathia (<ext-link ext-link-type="uri" xlink:href="http://hipathia.babelomics.org">http://hipathia.babelomics.org</ext-link>) to decompose KEGG pathways into signalling circuits, by transforming gene expression profiles into signal transduction activity profiles.<xref rid="bjd17698-bib-0023" ref-type="ref">23</xref> We found 42 overlapping circuits in the three genodermatoses when comparing them against controls (<xref rid="bjd17698-sup-0001" ref-type="supplementary-material">Fig.&#x000a0;S1a</xref>; see Supporting Information). Effectors were associated with cell proliferation (<italic>AREG</italic>,<italic> MAPK8</italic>), transforming growth factor (TGF)&#x02010;&#x003b2; signalling (<italic>PITX2</italic>) and ECM&#x02013;cell interactions (<italic>PLAU</italic>,<italic> MAP3K4</italic>) (highlighted terms in Table&#x000a0;<xref rid="bjd17698-sup-0007" ref-type="supplementary-material">S5</xref>; see Supporting Information). A particular example of these circuits includes activation of <italic>BCL2</italic> &#x02013; an effector molecule with an antiapoptotic effect &#x02013; initiated in multiple overexpressed nodes and propagated through the PI3K&#x02013;Akt pathway (<xref rid="bjd17698-sup-0001" ref-type="supplementary-material">Fig.&#x000a0;S1b</xref>; see Supporting Information).</p><p>To identify functional associations between the 186 differentially expressed genes, the STRING database<xref rid="bjd17698-bib-0024" ref-type="ref">24</xref> was used to generate PPI networks. The enrichment PPI <italic>P</italic>&#x02010;value (0&#x000b7;0013) indicates that the commonly altered genes do not represent a randomly scattered set of proteins, but a meaningfully connected set of genes in accordance with their biological functions. Three major clusters (A, B and C) of proteins were detected (Fig.&#x000a0;<xref rid="bjd17698-fig-0003" ref-type="fig">3</xref>). Cluster A includes a group of proteins, mostly downregulated, involved in signalling pathways and signal transduction (e.g. <italic>JAK3</italic>,<italic> PTK2B</italic> and <italic>PRKCQ</italic>). Interestingly, this cluster also contains the angiotensin II receptor (<italic>AGTR1</italic>, upregulated), a target of recent antifibrotic therapy tested in RDEB,<xref rid="bjd17698-bib-0028" ref-type="ref">28</xref> and the antioxidant enzyme extracellular superoxide dismutase (<italic>SOD3</italic>, downregulated), previously proposed as a repressor molecule of skin inflammation.<xref rid="bjd17698-bib-0029" ref-type="ref">29</xref>
</p><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Protein&#x02013;protein interaction network of the common dysregulated genes. The three largest connected components, labelled as clusters A, B and C, represent clusters of highly connected, biologically related proteins. The node colour is graded according to the average fold change (red, upregulated; green, downregulated in the disease). The edge width is proportional to the <styled-content style="fixed-case" toggle="no">STRING</styled-content> interaction score, which represents the confidence for that interaction. Groups of potentially interactive proteins with fewer nodes are shown below the main clusters. Proteins without interactions are not shown. The average node degree is 0&#x000b7;387 and the average local clustering coefficient is 0&#x000b7;158.</p></caption><graphic id="nlm-graphic-5" xlink:href="BJD-181-512-g003"/></fig><p>Cluster B is formed predominantly by a group of transcription factors (e.g. <italic>PITX2</italic>, a procollagen lysyl hydroxylase transcription factor). Cluster C is represented by matrisome and matrisome&#x02010;associated genes (<ext-link ext-link-type="uri" xlink:href="http://matrisomeproject.mit.edu">http://matrisomeproject.mit.edu</ext-link>),<xref rid="bjd17698-bib-0030" ref-type="ref">30</xref> implicated in the stabilization, deposition and remodelling of the ECM (e.g. <italic>TGFBI</italic>,<italic> FN1</italic>,<italic> TNC</italic> and <italic>POSTN</italic>). Among the minor&#x02010;clustered nodes, downregulation of the <italic>ALDH1A1</italic> gene received our attention. This gene encodes an antioxidant enzyme (aldehyde dehydrogenase 1A1) related to ultraviolet protection against oxidative stress<xref rid="bjd17698-bib-0031" ref-type="ref">31</xref> and is repressed by TGF&#x02010;&#x003b2;.<xref rid="bjd17698-bib-0032" ref-type="ref">32</xref> In our analysis, <italic>ALDH1A1</italic> is one of the most significantly underexpressed genes in the three diseases.</p></sec><sec id="bjd17698-sec-0018"><title>Validation of altered gene expression</title><p>Given the importance of the extracellular component &#x02013; evidenced by enriched gene ontology terms and KEGG pathways &#x02013; we took advantage of the STRING PPI and chose several proteins of cluster C for validation by Western blot (Fig.&#x000a0;<xref rid="bjd17698-fig-0004" ref-type="fig">4</xref>). In this analysis we included additional patient and control samples not used for RNA&#x02010;Seq (Table&#x000a0;<xref rid="bjd17698-sup-0003" ref-type="supplementary-material">S1b</xref>; see Supporting Information). In accordance with the transcriptomic data, fibulin&#x02010;1, transglutaminase&#x02010;2 and ALDH1A1 were underexpressed in the diseases, while expression of tenascin C, periostin and TGF&#x02010;&#x003b2; induced (TGF&#x02010;&#x003b2;I) was increased. In addition to the changes observed in these markers, we found high levels of &#x003b1;&#x02010;smooth muscle actin in all fibroblasts of all genodermatoses, confirming their activated phenotype (data not shown). Variability in protein expression levels in individual fibroblasts was observed; however, there was no evident pattern associated with body sites of origin or the age of the donors. Abnormal expression of some of these proteins has previously been described in RDEB fibroblasts,<xref rid="bjd17698-bib-0033" ref-type="ref">33</xref> but not the periostin overexpression. Thus, we decided to study their expression by immunofluorescence in available skin biopsy sections from patients with RDEB and KS. The analysis showed a degree and pattern of overexpression similar to those seen in tenascin C, used as a positive control (Fig.&#x000a0;<xref rid="bjd17698-fig-0005" ref-type="fig">5</xref>).</p><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Western blot validation of relevant genes. Immunoblot analysis of fibroblast cell lysates confirms the high expression of tenascin C, periostin and transforming growth factor&#x02010;&#x003b2; induced (<styled-content style="fixed-case" toggle="no">TGFBI</styled-content>), together with underexpression of transglutaminase&#x02010;2 (<styled-content style="fixed-case" toggle="no">TG</styled-content>2), aldehyde dehydrogenase 1A1 (<styled-content style="fixed-case" toggle="no">ALDH</styled-content>1A1) and fibulin&#x02010;1 in samples from patients with recessive dystrophic epidermolysis bullosa (<styled-content style="fixed-case" toggle="no">RDEB</styled-content>), xeroderma pigmentosum complementation group C (<styled-content style="fixed-case" toggle="no">XPC</styled-content>) and Kindler syndrome (<styled-content style="fixed-case" toggle="no">KS</styled-content>). Glyceraldehyde&#x02010;3&#x02010;phosphate dehydrogenase (<styled-content style="fixed-case" toggle="no">GAPDH</styled-content>) was used as the loading control. Samples not included in the <styled-content style="fixed-case" toggle="no">RNA</styled-content>&#x02010;Seq analysis are indicated by an asterisk (*). Ctrl, healthy control.</p></caption><graphic id="nlm-graphic-7" xlink:href="BJD-181-512-g004"/></fig><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Immunofluorescence <italic>in&#x000a0;situ</italic> validation of tenascin C (<styled-content style="fixed-case" toggle="no">TNC</styled-content>) and periostin (<styled-content style="fixed-case" toggle="no">POSTN</styled-content>). Skin biopsies sections from patients with recessive dystrophic epidermolysis bullosa (<styled-content style="fixed-case" toggle="no">RDEB</styled-content>) and Kindler syndrome (<styled-content style="fixed-case" toggle="no">KS</styled-content>) and healthy controls (Ctrl) were stained for (a) tenascin C and (b) periostin. Quantitation of fluorescence intensity was measured on five nonoverlapping microscopic fields per sample (ImageJ) and are represented as the mean &#x000b1; <styled-content style="fixed-case" toggle="no">SD</styled-content> staining intensity (<styled-content style="fixed-case" toggle="no">MFI</styled-content>) per area value. The data were analysed by Student's <italic>t</italic>&#x02010;test. *<italic>P</italic> &#x0003c; 0&#x000b7;05; **<italic>P</italic> &#x0003c; 0&#x000b7;01 vs. control.</p></caption><graphic id="nlm-graphic-9" xlink:href="BJD-181-512-g005"/></fig></sec><sec id="bjd17698-sec-0019"><title>Identification of serum periostin as a novel biomarker in recessive dystrophic epidermolysis bullosa</title><p>Increased levels of circulating periostin have been shown in several noninherited fibrotic conditions including cancer.<xref rid="bjd17698-bib-0034" ref-type="ref">34</xref>, <xref rid="bjd17698-bib-0035" ref-type="ref">35</xref> Considering the overexpression of periostin seen <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;situ</italic>, we subsequently searched for periostin in available serum samples of patients with RDEB and healthy donors. Consistently with the validation results, the mean &#x000b1; SEM circulating periostin concentration was remarkably higher in patients with RDEB (65&#x000b7;7 &#x000b1; 14&#x000b7;8 ng mL<sup>&#x02212;1</sup>; <italic>n</italic> = 16) than in controls (3&#x000b7;72 &#x000b1; 0&#x000b7;33 ng mL<sup>&#x02212;1</sup>; <italic>n</italic> = 10) (<italic>P</italic> &#x0003c; 0&#x000b7;001; Fig.&#x000a0;<xref rid="bjd17698-fig-0006" ref-type="fig">6</xref>). This result suggests that periostin may represent a potential biomarker in RDEB.</p><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Circulating periostin levels in patients with recessive dystrophic epidermolysis bullosa (<styled-content style="fixed-case" toggle="no">RDEB</styled-content>). The serum periostin concentration was significantly higher in patients with recessive dystrophic epidermolysis bullosa (mean &#x000b1; <styled-content style="fixed-case" toggle="no">SEM</styled-content> 65&#x000b7;7 &#x000b1; 14&#x000b7;8 ng <styled-content style="fixed-case" toggle="no">mL</styled-content>
<sup>&#x02212;1</sup>; <italic>n</italic> = 16) than in donor controls (3&#x000b7;72 &#x000b1; 0&#x000b7;33 ng <styled-content style="fixed-case" toggle="no">mL</styled-content>
<sup>&#x02212;1</sup>; <italic>n</italic> = 10). Two independent experiments were performed for each patient and control (Ctrl) sample. ***<italic>P</italic> &#x0003c; 0&#x000b7;001.</p></caption><graphic id="nlm-graphic-11" xlink:href="BJD-181-512-g006"/></fig></sec></sec><sec id="bjd17698-sec-0020"><title>Discussion</title><p>Here we conducted a global gene expression analysis of dermal fibroblasts &#x02013; isolated from uninvolved skin areas of patients with XPC, KS and RDEB &#x02013; with the goal of elucidating overlapping pathomechanisms in these cancer&#x02010;prone genodermatoses. Despite each disease's gene expression singularities, our study allowed us to identify a common signature of 227 transcripts and four KEGG pathways differentially expressed against healthy controls. Our different bioinformatic analyses revealed the presence of three major determinants of an activated fibroblast phenotype, namely increased cell survival, altered TGF&#x02010;&#x003b2; signalling and abnormal ECM remodelling.<xref rid="bjd17698-bib-0036" ref-type="ref">36</xref>, <xref rid="bjd17698-bib-0037" ref-type="ref">37</xref> It is known that fibroblasts become activated when they detect adverse cues from their surroundings (e.g. inflammation, mechanical trauma, TGF&#x02010;&#x003b2;, oxidative stress) and acquire a proliferative phenotype characterized by aberrant secretion of ECM molecules.<xref rid="bjd17698-bib-0038" ref-type="ref">38</xref> Normally, activated fibroblasts return to their original state when the injury is resolved, through reprogramming or apoptosis.<xref rid="bjd17698-bib-0039" ref-type="ref">39</xref> However, if the insult becomes chronic, fibroblasts become irreversibly active, just as occurs in CAFs and fibrosis&#x02010;associated fibroblasts.<xref rid="bjd17698-bib-0040" ref-type="ref">40</xref>
</p><p>The pathway inference analysis highlighted several nodes involving PI3K&#x02013;Akt signalling activation, ultimately triggering antiapoptotic and hyperproliferative stimuli via the BCL2 effector protein. Earlier studies on RDEB have also shown that increased PI3K&#x02013;Akt signalling mediates cell survival and cSCC development. Indeed, it was proposed as one pharmacological target to prevent disease progression.<xref rid="bjd17698-bib-0041" ref-type="ref">41</xref> On the other hand, ontologies and categories referred to an altered activity of the cellular exterior, resulting in altered production of the chemokine repertoire and abnormal expression of the matrisome and matrisome&#x02010;associated genes.</p><p>The involvement of aberrantly expressed ECM proteins (e.g. tenascin C, fibulin&#x02010;1, transglutaminase&#x02010;2 and TGF&#x02010;&#x003b2;I) was previously associated with loss of C7.<xref rid="bjd17698-bib-0033" ref-type="ref">33</xref>, <xref rid="bjd17698-bib-0042" ref-type="ref">42</xref> Overexpression of tenascin C and TGF&#x02010;&#x003b2; activation have also been shown in KS fibroblasts.<xref rid="bjd17698-bib-0014" ref-type="ref">14</xref> To our knowledge, abnormal expression of periostin has not yet been reported in nontumoral XPC, KS or RDEB fibroblasts, but it was recently shown in RDEB cSCC biopsies.<xref rid="bjd17698-bib-0043" ref-type="ref">43</xref> Periostin and tenascin C are induced by skin damage, promoting the activation of fibroblasts to repair the wound. Their overexpression has been linked to pathogenic roles in chronic inflammation, fibrosis and cancer.<xref rid="bjd17698-bib-0034" ref-type="ref">34</xref>, <xref rid="bjd17698-bib-0044" ref-type="ref">44</xref>, <xref rid="bjd17698-bib-0045" ref-type="ref">45</xref>
</p><p>Different studies have shown that elevated levels of serum periostin are associated with progression and disease severity in pulmonary fibrosis,<xref rid="bjd17698-bib-0046" ref-type="ref">46</xref> colorectal cancer<xref rid="bjd17698-bib-0047" ref-type="ref">47</xref>, <xref rid="bjd17698-bib-0048" ref-type="ref">48</xref> and systemic sclerosis.<xref rid="bjd17698-bib-0049" ref-type="ref">49</xref> Our workflow from RNA&#x02010;Seq to validation at the protein level allowed us to disclose periostin as a possible systemic biomarker, at least in RDEB (due to sample availability). Currently, several experimental antifibrotic therapies are under investigation for this disease.<xref rid="bjd17698-bib-0028" ref-type="ref">28</xref> Considering the paucity of available minimally invasive biomarkers to assess treatment efficacy, circulating periostin may be a useful molecule to consider. Further studies will be necessary to extend these results to XPC and KS.</p><p>A general inferred notion from previous studies was that causal defects, such as loss of C7 or kindlin&#x02010;1, could be responsible for the abnormal ECM expression in RDEB and KS dermal fibroblasts.<xref rid="bjd17698-bib-0014" ref-type="ref">14</xref>, <xref rid="bjd17698-bib-0050" ref-type="ref">50</xref>, <xref rid="bjd17698-bib-0051" ref-type="ref">51</xref> However, without excluding a triggering effect due to the primary deficiencies, our results challenge the view of a direct genetic cause&#x02010;driven effect. Rather, they stand for the existence of a shared injury&#x02010;responsive event able to transduce the primary defect into epigenetic changes, leading to an activated phenotype (Fig.&#x000a0;<xref rid="bjd17698-fig-0007" ref-type="fig">7</xref>). A likely candidate appears to be TGF&#x02010;&#x003b2;, as a large proportion of the common dysregulated genes (e.g. <italic>TNC</italic>,<italic> POSTN</italic>,<italic> FN1</italic>,<italic> TGFBI</italic> and <italic>ALDH1A1</italic>) are modulated by this factor. Another possible candidate, already shown in XPC and KS,<xref rid="bjd17698-bib-0010" ref-type="ref">10</xref>, <xref rid="bjd17698-bib-0052" ref-type="ref">52</xref>, <xref rid="bjd17698-bib-0053" ref-type="ref">53</xref>, <xref rid="bjd17698-bib-0054" ref-type="ref">54</xref> is oxidative stress, which could be able, by itself or through interaction with TGF&#x02010;&#x003b2;, to trigger fibroblast activation and ECM accumulation.<xref rid="bjd17698-bib-0055" ref-type="ref">55</xref>, <xref rid="bjd17698-bib-0056" ref-type="ref">56</xref> In this context, downregulation of the <italic>ALDH1A1</italic> and <italic>SOD3</italic> genes, encoding antioxidant enzymes, could facilitate oxidative stress&#x02010;induced damage. Similar expression changes in <italic>ALDH1A1</italic> were recently described as part of the myofibroblast&#x02010;specific expression profile in mouse skin wounds.<xref rid="bjd17698-bib-0057" ref-type="ref">57</xref> In fact, an <italic>in silico</italic> comparison of our 186 dysregulated genes disclosed 41 overlapping genes included in the transcriptomic signature of mouse wound myofibroblasts. Overexpression of <italic>POSTN</italic> and <italic>TNC</italic> stands out among these 41 genes (<xref rid="bjd17698-sup-0002" ref-type="supplementary-material">Fig.&#x000a0;S2</xref>; see Supporting Information).</p><fig fig-type="Figure" xml:lang="en" id="bjd17698-fig-0007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Model of the common pathomechanism suggested for recessive dystrophic epidermolysis bullosa (<styled-content style="fixed-case" toggle="no">RDEB</styled-content>), xeroderma pigmentosum complementation group C (<styled-content style="fixed-case" toggle="no">XPC</styled-content>) and Kindler syndrome (<styled-content style="fixed-case" toggle="no">KS</styled-content>). Fibroblasts in the different genodermatoses respond similarly to tissue injury and inflammation. These persistent stimuli may converge into the activation of transforming growth factor (<styled-content style="fixed-case" toggle="no">TGF</styled-content>)&#x02010;&#x003b2; signalling and oxidative imbalance, which lead to overexpression of extracellular matrix (<styled-content style="fixed-case" toggle="no">ECM</styled-content>) proteins (e.g. tenascin C, <styled-content style="fixed-case" toggle="no">TNC</styled-content>; periostin, <styled-content style="fixed-case" toggle="no">POSTN</styled-content>; and fibronectin 1, <styled-content style="fixed-case" toggle="no">FN</styled-content>1) and reduced expression of antioxidant enzymes (e.g. aldehyde dehydrogenase 1A1, <styled-content style="fixed-case" toggle="no">ALDH</styled-content>1A1; and superoxide dismutase, <styled-content style="fixed-case" toggle="no">SOD</styled-content>3). Reciprocal regulation between <styled-content style="fixed-case" toggle="no">TGF</styled-content>&#x02010;&#x003b2; and reactive oxygen species (<styled-content style="fixed-case" toggle="no">ROS</styled-content>) allows the acquisition of an activated and synthetic fibroblast phenotype and may promote disease progression. <styled-content style="fixed-case" toggle="no">FBLN</styled-content>1, fibulin 1; <styled-content style="fixed-case" toggle="no">TGM</styled-content>2, transglutaminase 2.</p></caption><graphic id="nlm-graphic-13" xlink:href="BJD-181-512-g007"/></fig><p>Examination of the exclusive transcriptional features of each disease may also offer interesting results, concerning the differential characteristics of each condition. However, these specific expression changes were not the focus of this study and should be considered separately. All in all, the common genetic signature in fibroblasts of the three genodermatoses shares some similarities with that found in myofibroblasts,<xref rid="bjd17698-bib-0057" ref-type="ref">57</xref> wound&#x02010;activated fibroblasts and cutaneous CAFs.<xref rid="bjd17698-bib-0011" ref-type="ref">11</xref> The common mechanisms of the three diseases would allow consideration of symptom&#x02010;relief therapies currently tested in RDEB to be used also in XPC and KS. In addition, newly elucidated molecular targets, such as those involved in derangement of the oxidative state, could be subject to novel pharmacological approaches.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="bjd17698-sup-0001"><caption><p>
<bold>Fig S1.</bold> Pathway activity analysis.</p></caption><media xlink:href="BJD-181-512-s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0002"><caption><p>
<bold>Fig S2.</bold> Venn diagram of dysregulated genes in myofibroblasts and genodermatoses fibroblasts.</p></caption><media xlink:href="BJD-181-512-s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0003"><caption><p>
<bold>Table&#x000a0;S1.</bold> Patient information: age, sex and gene and protein mutations of all patient and control samples.</p></caption><media xlink:href="BJD-181-512-s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0004"><caption><p>
<bold>Table&#x000a0;S2.</bold> Normalized RNA&#x02010;Seq counts for all genes and all samples.</p></caption><media xlink:href="BJD-181-512-s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0005"><caption><p>
<bold>Table&#x000a0;S3.</bold> Differentially expressed genes.</p></caption><media xlink:href="BJD-181-512-s005.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0006"><caption><p>
<bold>Table&#x000a0;S4.</bold> Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis.</p></caption><media xlink:href="BJD-181-512-s006.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0007"><caption><p>
<bold>Table&#x000a0;S5.</bold> Pathway activity analysis. </p></caption><media xlink:href="BJD-181-512-s007.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="bjd17698-sup-0008"><caption><p>
<bold>Powerpoint S1.</bold> Journal Club Slide Set.</p></caption><media xlink:href="BJD-181-512-s008.pptx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list content-type="cited-references" id="bjd17698-bibl-0001"><title>References</title><ref id="bjd17698-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="bjd17698-cit-0001">
<string-name>
<surname>DeStefano</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Christiano</surname>
<given-names>AM</given-names>
</string-name>. <article-title>The genetics of human skin disease</article-title>. <source xml:lang="en">Cold Spring Harb Perspect Med</source>
<year>2014</year>; <volume>4</volume>:<fpage>a015172</fpage>.<pub-id pub-id-type="pmid">25274756</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="bjd17698-cit-0002">
<string-name>
<surname>Fine</surname>
<given-names>J&#x02010;D</given-names>
</string-name>, <string-name>
<surname>Bruckner&#x02010;Tuderman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Eady</surname>
<given-names>RAJ</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification</article-title>. <source xml:lang="en">J Am Acad Dermatol</source>
<year>2014</year>; <volume>70</volume>:<fpage>1103</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">24690439</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="bjd17698-cit-0003">
<string-name>
<surname>Lotem</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Raben</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zeltser</surname>
<given-names>R</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high&#x02010;dose radiation therapy and granulocyte&#x02013;macrophage colony&#x02010;stimulating factor</article-title>. <source xml:lang="en">Br J Dermatol</source>
<year>2001</year>; <volume>144</volume>:<fpage>1284</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">11422071</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="bjd17698-cit-0004">
<string-name>
<surname>Jobard</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bouadjar</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Caux</surname>
<given-names>F</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome</article-title>. <source xml:lang="en">Hum Mol Genet</source>
<year>2003</year>; <volume>12</volume>:<fpage>925</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">12668616</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="bjd17698-cit-0005">
<string-name>
<surname>Siegel</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Ashton</surname>
<given-names>GHS</given-names>
</string-name>, <string-name>
<surname>Penagos</surname>
<given-names>HG</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Loss of kindlin&#x02010;1, a human homolog of the <italic>Caenorhabditis elegans</italic> actin&#x02013;extracellular&#x02010;matrix linker protein UNC&#x02010;112, causes Kindler syndrome</article-title>. <source xml:lang="en">Am J Hum Genet</source>
<year>2003</year>; <volume>73</volume>:<fpage>174</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">12789646</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="bjd17698-cit-0006">
<string-name>
<surname>Kraemer</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Scotto</surname>
<given-names>J</given-names>
</string-name>. <article-title>Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases</article-title>. <source xml:lang="en">Arch Dermatol</source>
<year>1987</year>; <volume>123</volume>:<fpage>241</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">3545087</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="bjd17698-cit-0007">
<string-name>
<surname>DiGiovanna</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Kraemer</surname>
<given-names>KH</given-names>
</string-name>. <article-title>Shining a light on xeroderma pigmentosum</article-title>. <source xml:lang="en">J Invest Dermatol</source>
<year>2012</year>; <volume>132</volume>:<fpage>785</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">22217736</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="bjd17698-cit-0008">
<string-name>
<surname>Rezvani</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Rossignol</surname>
<given-names>R</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas</article-title>. <source xml:lang="en">J Clin Invest</source>
<year>2011</year>; <volume>121</volume>:<fpage>195</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">21123941</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="bjd17698-cit-0009">
<string-name>
<surname>Breitenbach</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Rinnerthaler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Trost</surname>
<given-names>A</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Transcriptome and ultrastructural changes in dystrophic epidermolysis bullosa resemble skin aging</article-title>. <source xml:lang="en">Aging (Albany NY)</source>
<year>2015</year>; <volume>7</volume>:<fpage>389</fpage>&#x02013;<lpage>411</lpage>.<pub-id pub-id-type="pmid">26143532</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="bjd17698-cit-0010">
<string-name>
<surname>Maier</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>W&#x000f6;lfle</surname>
<given-names>U</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>UV&#x02010;B&#x02010;induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome</article-title>. <source xml:lang="en">Hum Mol Genet</source>
<year>2016</year>; <volume>25</volume>:<fpage>5339</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">27798104</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="bjd17698-cit-0011">
<string-name>
<surname>Ng</surname>
<given-names>Y&#x02010;Z</given-names>
</string-name>, <string-name>
<surname>Pourreyron</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Salas&#x02010;Alanis</surname>
<given-names>JC</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Fibroblast&#x02010;derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa</article-title>. <source xml:lang="en">Cancer Res</source>
<year>2012</year>; <volume>72</volume>:<fpage>3522</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">22564523</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="bjd17698-cit-0012">
<string-name>
<surname>Bernerd</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Asselineau</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Vioux</surname>
<given-names>C</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Clues to epidermal cancer proneness revealed by reconstruction of DNA repair&#x02010;deficient xeroderma pigmentosum skin <italic>in&#x000a0;vitro</italic>
</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source>
<year>2001</year>; <volume>98</volume>:<fpage>7817</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">11438733</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="bjd17698-cit-0013">
<string-name>
<surname>Fr&#x000e9;chet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Warrick</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Vioux</surname>
<given-names>C</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair&#x02010;deficient/cancer&#x02010;prone xeroderma pigmentosum group C patients</article-title>. <source xml:lang="en">Oncogene</source>
<year>2008</year>; <volume>27</volume>:<fpage>5223</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">18469853</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="bjd17698-cit-0014">
<string-name>
<surname>Heinemann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zimina</surname>
<given-names>E</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Induction of phenotype modifying cytokines by <italic>FERMT1</italic> mutations</article-title>. <source xml:lang="en">Hum Mutat</source>
<year>2011</year>; <volume>32</volume>:<fpage>397</fpage>&#x02013;<lpage>406</lpage>.<pub-id pub-id-type="pmid">21309038</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="bjd17698-cit-0015">
<string-name>
<surname>Zamarr&#x000f3;n</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Garc&#x000ed;a</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Del R&#x000ed;o</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Effects of photodynamic therapy on dermal fibroblasts from xeroderma pigmentosum and Gorlin&#x02010;Goltz syndrome patients</article-title>. <source xml:lang="en">Oncotarget</source>
<year>2017</year>; <volume>8</volume>:<fpage>77385</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">29100394</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="bjd17698-cit-0016">
<string-name>
<surname>Meana</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Iglesias</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Del Rio</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast&#x02010;containing fibrin gels</article-title>. <source xml:lang="en">Burns</source>
<year>1998</year>; <volume>24</volume>:<fpage>621</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">9882060</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="bjd17698-cit-0017">
<string-name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Oshlack</surname>
<given-names>A</given-names>
</string-name>. <article-title>A scaling normalization method for differential expression analysis of RNA&#x02010;seq data</article-title>. <source xml:lang="en">Genome Biol</source>
<year>2010</year>; <volume>11</volume>:<fpage>R25</fpage>.<pub-id pub-id-type="pmid">20196867</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="bjd17698-cit-0018">
<string-name>
<surname>Johnson</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rabinovic</surname>
<given-names>A</given-names>
</string-name>. <article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>. <source xml:lang="en">Biostatistics</source>
<year>2007</year>; <volume>8</volume>:<fpage>118</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">16632515</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="bjd17698-cit-0019">
<string-name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</string-name>. <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source xml:lang="en">Bioinformatics</source>
<year>2010</year>; <volume>26</volume>:<fpage>139</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="bjd17698-cit-0020">
<string-name>
<surname>Benjamini</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hochberg</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source xml:lang="en">J Royal Stat Soc B</source>
<year>1995</year>; <volume>57</volume>:<fpage>289</fpage>&#x02013;<lpage>300</lpage>.</mixed-citation></ref><ref id="bjd17698-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="bjd17698-cit-0021">
<string-name>
<surname>Alonso</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Salavert</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Garcia&#x02010;Garcia</surname>
<given-names>F</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Babelomics 5.0: functional interpretation for new generations of genomic data</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>2015</year>; <volume>43</volume>:<fpage>W117</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">25897133</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="bjd17698-cit-0022">
<string-name>
<surname>Huang</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Sherman</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>2009</year>; <volume>37</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">19033363</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="bjd17698-cit-0023">
<string-name>
<surname>Hidalgo</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Cubuk</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Amadoz</surname>
<given-names>A</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes</article-title>. <source xml:lang="en">Oncotarget</source>
<year>2017</year>; <volume>8</volume>:<fpage>5160</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">28042959</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="bjd17698-cit-0024">
<string-name>
<surname>Szklarczyk</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Franceschini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wyder</surname>
<given-names>S</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>STRING v10: protein&#x02013;protein interaction networks, integrated over the tree of life</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>2015</year>; <volume>43</volume>:<fpage>D447</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">25352553</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="bjd17698-cit-0025">
<string-name>
<surname>Esc&#x000e1;mez</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Garc&#x000ed;a</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cuadrado&#x02010;Corrales</surname>
<given-names>N</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>The first <italic>COL7A1</italic> mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation</article-title>. <source xml:lang="en">Br J Dermatol</source>
<year>2010</year>; <volume>163</volume>:<fpage>155</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">20184583</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="bjd17698-cit-0026">
<string-name>
<surname>Ashburner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ball</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Blake</surname>
<given-names>JA</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Gene ontology: tool for the unification of biology</article-title>. <source xml:lang="en">Nat Genet</source>
<year>2000</year>; <volume>25</volume>:<fpage>25</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="bjd17698-cit-0027">
<string-name>
<surname>Kanehisa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>Y</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>KEGG for integration and interpretation of large&#x02010;scale molecular data sets</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<year>2012</year>; <volume>40</volume>:<fpage>D109</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">22080510</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="bjd17698-cit-0028">
<string-name>
<surname>Nystr&#x000f6;m</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thriene</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mittapalli</surname>
<given-names>V</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms</article-title>. <source xml:lang="en">EMBO Mol Med</source>
<year>2015</year>; <volume>7</volume>:<fpage>1211</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">26194911</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="bjd17698-cit-0029">
<string-name>
<surname>Kwon</surname>
<given-names>M&#x02010;J</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>T&#x02010;Y</given-names>
</string-name>. <article-title>Role of superoxide dismutase 3 in skin inflammation</article-title>. <source xml:lang="en">J Dermatol Sci</source>
<year>2012</year>; <volume>67</volume>:<fpage>81</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22763488</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="bjd17698-cit-0030">
<string-name>
<surname>Naba</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Clauser</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>H</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>The extracellular matrix: tools and insights for the &#x02018;omics&#x02019; era</article-title>. <source xml:lang="en">Matrix Biol</source>
<year>2016</year>; <volume>49</volume>:<fpage>10</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">26163349</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="bjd17698-cit-0031">
<string-name>
<surname>Lassen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bateman</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Estey</surname>
<given-names>T</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Multiple and additive functions of ALDH3A1 and ALDH1A1</article-title>. <source xml:lang="en">J Biol Chem</source>
<year>2007</year>; <volume>282</volume>:<fpage>25668</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">17567582</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="bjd17698-cit-0032">
<string-name>
<surname>Hoshino</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nishida</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Katsuno</surname>
<given-names>Y</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Smad4 decreases the population of pancreatic cancer&#x02010;initiating cells through transcriptional repression of ALDH1A1</article-title>. <source xml:lang="en">Am J Pathol</source>
<year>2015</year>; <volume>185</volume>:<fpage>1457</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">25769430</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="bjd17698-cit-0033">
<string-name>
<surname>K&#x000fc;ttner</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mack</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rigbolt</surname>
<given-names>KTG</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Global remodelling of cellular microenvironment due to loss of collagen VII</article-title>. <source xml:lang="en">Mol Syst Biol</source>
<year>2013</year>; <volume>9</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="bjd17698-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="bjd17698-cit-0034">
<string-name>
<surname>Yamaguchi</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Periostin in skin tissue skin&#x02010;related diseases</article-title>. <source xml:lang="en">Allergol Int</source>
<year>2014</year>; <volume>63</volume>:<fpage>161</fpage>&#x02013;<lpage>70</lpage>.</mixed-citation></ref><ref id="bjd17698-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="bjd17698-cit-0035">
<string-name>
<surname>Gonz&#x000e1;lez&#x02010;Gonz&#x000e1;lez</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Alonso</surname>
<given-names>J</given-names>
</string-name>. <article-title>Periostin: a matricellular protein with multiple functions in cancer development and progression</article-title>. <source xml:lang="en">Front Oncol</source>
<year>2018</year>; <volume>8</volume>:<fpage>225</fpage>.<pub-id pub-id-type="pmid">29946533</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="bjd17698-cit-0036">
<string-name>
<surname>Tomasek</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Gabbiani</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hinz</surname>
<given-names>B</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Myofibroblasts and mechano&#x02010;regulation of connective tissue remodelling</article-title>. <source xml:lang="en">Nat Rev Mol Cell Biol</source>
<year>2002</year>; <volume>3</volume>:<fpage>349</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">11988769</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="bjd17698-cit-0037">
<string-name>
<surname>Parsonage</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Filer</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Haworth</surname>
<given-names>O</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>A stromal address code defined by fibroblasts</article-title>. <source xml:lang="en">Trends Immunol</source>
<year>2005</year>; <volume>26</volume>:<fpage>150</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">15745857</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="bjd17698-cit-0038">
<string-name>
<surname>Vong</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kalluri</surname>
<given-names>R</given-names>
</string-name>. <article-title>The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis</article-title>. <source xml:lang="en">Genes Cancer</source>
<year>2011</year>; <volume>2</volume>:<fpage>1139</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">22866205</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="bjd17698-cit-0039">
<string-name>
<surname>Micallef</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vedrenne</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Billet</surname>
<given-names>F</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>The myofibroblast, multiple origins for major roles in normal and pathological tissue repair</article-title>. <source xml:lang="en">Fibrogenesis Tissue Repair</source>
<year>2012</year>; <volume>5</volume> (<issue>Suppl. 1</issue>):<fpage>S5</fpage>.<pub-id pub-id-type="pmid">23259712</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="bjd17698-cit-0040">
<string-name>
<surname>Kalluri</surname>
<given-names>R</given-names>
</string-name>. <article-title>The biology and function of fibroblasts in cancer</article-title>. <source xml:lang="en">Nat Rev Cancer</source>
<year>2016</year>; <volume>16</volume>:<fpage>582</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">27550820</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="bjd17698-cit-0041">
<string-name>
<surname>Mittapalli</surname>
<given-names>VR</given-names>
</string-name>, <string-name>
<surname>Madl</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>L&#x000f6;ffek</surname>
<given-names>S</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Injury&#x02010;driven stiffening of the dermis expedites skin carcinoma progression</article-title>. <source xml:lang="en">Cancer Res</source>
<year>2016</year>; <volume>76</volume>:<fpage>940</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">26676755</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="bjd17698-cit-0042">
<string-name>
<surname>K&#x000fc;ttner</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mack</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gretzmeier</surname>
<given-names>C</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Loss of collagen VII is associated with reduced transglutaminase 2 abundance and activity</article-title>. <source xml:lang="en">J Invest Dermatol</source>
<year>2014</year>; <volume>134</volume>:<fpage>2381</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">24732400</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="bjd17698-cit-0043">
<string-name>
<surname>F&#x000f6;ll</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Fahrner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gretzmeier</surname>
<given-names>C</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high&#x02010;risk cutaneous squamous cell carcinomas</article-title>. <source xml:lang="en">Matrix Biol</source>
<year>2018</year>; <volume>66</volume>:<fpage>1</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">29158163</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="bjd17698-cit-0044">
<string-name>
<surname>Midwood</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Chiquet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tucker</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Orend</surname>
<given-names>G</given-names>
</string-name>. <article-title>Tenascin&#x02010;C at a glance</article-title>. <source xml:lang="en">J Cell Sci</source>
<year>2016</year>; <volume>129</volume>:<fpage>4321</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">27875272</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="bjd17698-cit-0045">
<string-name>
<surname>Yang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Serada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fujimoto</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma</article-title>. <source xml:lang="en">PLOS ONE</source>
<year>2012</year>; <volume>7</volume>:<fpage>e41994</fpage>.<pub-id pub-id-type="pmid">22911870</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="bjd17698-cit-0046">
<string-name>
<surname>Naik</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Bozyk</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Bentley</surname>
<given-names>JK</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis</article-title>. <source xml:lang="en">Am J Physiol Lung Cell Mol Physiol</source>
<year>2012</year>; <volume>303</volume>:<fpage>L1046</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">23043074</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="bjd17698-cit-0047">
<string-name>
<surname>Ben</surname>
<given-names>Q&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Ge</surname>
<given-names>S&#x02010;F</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Circulating levels of periostin may help identify patients with more aggressive colorectal cancer</article-title>. <source xml:lang="en">Int J Oncol</source>
<year>2009</year>; <volume>34</volume>:<fpage>821</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">19212687</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="bjd17698-cit-0048">
<string-name>
<surname>Dong</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>L</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Identification of serum periostin as a potential diagnostic and prognostic marker for colorectal cancer</article-title>. <source xml:lang="en">Clin Lab</source>
<year>2018</year>; <volume>64</volume>:<fpage>973</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">29945311</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="bjd17698-cit-0049">
<string-name>
<surname>Yamaguchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ono</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Masuoka</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis</article-title>. <source xml:lang="en">Br J Dermatol</source>
<year>2013</year>; <volume>168</volume>:<fpage>717</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">23110679</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="bjd17698-cit-0050">
<string-name>
<surname>Cianfarani</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zambruno</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Castiglia</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Odorisio</surname>
<given-names>T</given-names>
</string-name>. <article-title>Pathomechanisms of altered wound healing in recessive dystrophic epidermolysis bullosa</article-title>. <source xml:lang="en">Am J Pathol</source>
<year>2017</year>; <volume>187</volume>:<fpage>1445</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">28460207</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="bjd17698-cit-0051">
<string-name>
<surname>Bruckner&#x02010;Tuderman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Has</surname>
<given-names>C</given-names>
</string-name>. <article-title>Disorders of the cutaneous basement membrane zone &#x02013; the paradigm of epidermolysis bullosa</article-title>. <source xml:lang="en">Matrix Biol</source>
<year>2014</year>; <volume>33</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">23917088</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="bjd17698-cit-0052">
<string-name>
<surname>Zapatero&#x02010;Solana</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Garc&#x000ed;a&#x02010;Gim&#x000e9;nez</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Guerrero&#x02010;Aspizua</surname>
<given-names>S</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Oxidative stress and mitochondrial dysfunction in Kindler syndrome</article-title>. <source xml:lang="en">Orphanet J Rare Dis</source>
<year>2014</year>; <volume>9</volume>:<fpage>211</fpage>.<pub-id pub-id-type="pmid">25528446</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="bjd17698-cit-0053">
<string-name>
<surname>Emmert</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brunton</surname>
<given-names>VG</given-names>
</string-name>. <article-title>Kindlin&#x02010;1 protects cells from oxidative damage through activation of ERK signalling</article-title>. <source xml:lang="en">Free Radic Biol Med</source>
<year>2017</year>; <volume>108</volume>:<fpage>896</fpage>&#x02013;<lpage>903</lpage>.<pub-id pub-id-type="pmid">28501563</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="bjd17698-cit-0054">
<string-name>
<surname>Hosseini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ezzedine</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Taieb</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rezvani</surname>
<given-names>HR</given-names>
</string-name>. <article-title>Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders</article-title>. <source xml:lang="en">J Invest Dermatol</source>
<year>2015</year>; <volume>135</volume>:<fpage>341</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">25296907</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="bjd17698-cit-0055">
<string-name>
<surname>Liu</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Desai</surname>
<given-names>LP</given-names>
</string-name>. <article-title>Reciprocal regulation of TGF&#x02010;&#x003b2; and reactive oxygen species: a perverse cycle for fibrosis</article-title>. <source xml:lang="en">Redox Biol</source>
<year>2015</year>; <volume>6</volume>:<fpage>565</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">26496488</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="bjd17698-cit-0056">
<string-name>
<surname>Richter</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kietzmann</surname>
<given-names>T</given-names>
</string-name>. <article-title>Reactive oxygen species and fibrosis: further evidence of a significant liaison</article-title>. <source xml:lang="en">Cell Tissue Res</source>
<year>2016</year>; <volume>365</volume>:<fpage>591</fpage>&#x02013;<lpage>605</lpage>.<pub-id pub-id-type="pmid">27345301</pub-id></mixed-citation></ref><ref id="bjd17698-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="bjd17698-cit-0057">
<string-name>
<surname>Bergmeier</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Etich</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Pitzler</surname>
<given-names>L</given-names>
</string-name>
<italic>et&#x000a0;al</italic>
<article-title>Identification of a myofibroblast&#x02010;specific expression signature in skin wounds</article-title>. <source xml:lang="en">Matrix Biol</source>
<year>2018</year>; <volume>65</volume>:<fpage>59</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">28797711</pub-id></mixed-citation></ref></ref-list></back></article>